Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Prospective, high-throughput molecular profiling of human gliomas.

Chi AS, Batchelor TT, Dias-Santagata D, Borger D, Stiles CD, Wang DL, Curry WT, Wen PY, Ligon KL, Ellisen L, Louis DN, Iafrate AJ.

J Neurooncol. 2012 Oct;110(1):89-98. doi: 10.1007/s11060-012-0938-9. Epub 2012 Jul 22.

PMID:
22821383
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

van den Bent MJ, Dubbink HJ, Marie Y, Brandes AA, Taphoorn MJ, Wesseling P, Frenay M, Tijssen CC, Lacombe D, Idbaih A, van Marion R, Kros JM, Dinjens WN, Gorlia T, Sanson M.

Clin Cancer Res. 2010 Mar 1;16(5):1597-604. doi: 10.1158/1078-0432.CCR-09-2902. Epub 2010 Feb 16.

PMID:
20160062
[PubMed - indexed for MEDLINE]
Free Article
3.

Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.

Ren X, Cui X, Lin S, Wang J, Jiang Z, Sui D, Li J, Wang Z.

PLoS One. 2012;7(3):e32764. doi: 10.1371/journal.pone.0032764. Epub 2012 Mar 12.

PMID:
22427879
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.

Gravendeel LA, Kloosterhof NK, Bralten LB, van Marion R, Dubbink HJ, Dinjens W, Bleeker FE, Hoogenraad CC, Michiels E, Kros JM, van den Bent M, Smitt PA, French PJ.

Hum Mutat. 2010 Mar;31(3):E1186-99. doi: 10.1002/humu.21201.

PMID:
20077503
[PubMed - indexed for MEDLINE]
5.

Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.

Mukasa A, Takayanagi S, Saito K, Shibahara J, Tabei Y, Furuya K, Ide T, Narita Y, Nishikawa R, Ueki K, Saito N.

Cancer Sci. 2012 Mar;103(3):587-92. doi: 10.1111/j.1349-7006.2011.02175.x. Epub 2012 Jan 13.

PMID:
22136423
[PubMed - indexed for MEDLINE]
6.

Molecular diagnostics of gliomas: state of the art.

Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G.

Acta Neuropathol. 2010 Nov;120(5):567-84. doi: 10.1007/s00401-010-0736-4. Epub 2010 Aug 17. Review.

PMID:
20714900
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Genetic alterations and biomarkers for glioma].

Nagane M.

Brain Nerve. 2012 May;64(5):537-48. Review. Japanese.

PMID:
22570067
[PubMed - indexed for MEDLINE]
8.

Molecular subtypes of glioma identified by genome-wide methylation profiling.

Kloosterhof NK, de Rooi JJ, Kros M, Eilers PH, Sillevis Smitt PA, van den Bent MJ, French PJ.

Genes Chromosomes Cancer. 2013 Jul;52(7):665-74. doi: 10.1002/gcc.22062. Epub 2013 Apr 30.

PMID:
23629961
[PubMed - indexed for MEDLINE]
9.

MGMT promoter methylation in malignant gliomas.

Riemenschneider MJ, Hegi ME, Reifenberger G.

Target Oncol. 2010 Sep;5(3):161-5. doi: 10.1007/s11523-010-0153-6. Epub 2010 Aug 20. Review.

PMID:
20725792
[PubMed - indexed for MEDLINE]
10.

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Weller M, Stupp R, Hegi ME, van den Bent M, Tonn JC, Sanson M, Wick W, Reifenberger G.

Neuro Oncol. 2012 Sep;14 Suppl 4:iv100-8. doi: 10.1093/neuonc/nos206. Review.

PMID:
23095825
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Profiling critical cancer gene mutations in clinical tumor samples.

MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA.

PLoS One. 2009 Nov 18;4(11):e7887. doi: 10.1371/journal.pone.0007887. Erratum in: PLoS One. 2010;5(9). doi: 10.1371/annotation/3a0c8fee-57ef-43ed-b6c2-55b503e6db5e. PLoS One. 2010;5(9). doi: 10.1371/annotation/613c7509-e4c9-42ac-82fb-fc504400d9e0.

PMID:
19924296
[PubMed - indexed for MEDLINE]
Free PMC Article
12.
13.

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Gömöri E, Pál J, Kovács B, Dóczi T.

Diagn Pathol. 2012 Jan 20;7:8. doi: 10.1186/1746-1596-7-8.

PMID:
22264301
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches.

Riemenschneider MJ, Reifenberger G.

Curr Opin Neurol. 2009 Dec;22(6):619-24. doi: 10.1097/WCO.0b013e32833245b0. Review.

PMID:
19741528
[PubMed - indexed for MEDLINE]
15.

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group.

Yan W, Zhang W, You G, Zhang J, Han L, Bao Z, Wang Y, Liu Y, Jiang C, Kang C, You Y, Jiang T.

Neuro Oncol. 2012 Dec;14(12):1432-40. doi: 10.1093/neuonc/nos263. Epub 2012 Oct 22.

PMID:
23090983
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.

Grzendowski M, Wolter M, Riemenschneider MJ, Knobbe CB, Schlegel U, Meyer HE, Reifenberger G, Stühler K.

Neuro Oncol. 2010 Mar;12(3):243-56. doi: 10.1093/neuonc/nop025. Epub 2010 Jan 7.

PMID:
20167812
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.

Laffaire J, Everhard S, Idbaih A, Crinière E, Marie Y, de Reyniès A, Schiappa R, Mokhtari K, Hoang-Xuan K, Sanson M, Delattre JY, Thillet J, Ducray F.

Neuro Oncol. 2011 Jan;13(1):84-98. doi: 10.1093/neuonc/noq110. Epub 2010 Oct 5.

PMID:
20926426
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.

Mellai M, Piazzi A, Caldera V, Monzeglio O, Cassoni P, Valente G, Schiffer D.

J Neurooncol. 2011 Nov;105(2):345-57. doi: 10.1007/s11060-011-0596-3. Epub 2011 Jun 4.

PMID:
21643842
[PubMed - indexed for MEDLINE]
19.

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.

Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ.

J Clin Oncol. 2010 Jun 20;28(18):3061-8. doi: 10.1200/JCO.2009.26.7252. Epub 2010 May 17.

PMID:
20479398
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

Gravendeel LA, Kouwenhoven MC, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, Daemen A, Bleeker FE, Bralten LB, Kloosterhof NK, De Moor B, Eilers PH, van der Spek PJ, Kros JM, Sillevis Smitt PA, van den Bent MJ, French PJ.

Cancer Res. 2009 Dec 1;69(23):9065-72. doi: 10.1158/0008-5472.CAN-09-2307. Epub 2009 Nov 17.

PMID:
19920198
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk